INTRODUCTION 77
Chronic pain is a maladaptive condition in which the sensation of pain persists in the 78 absence of an eliciting stimulus. It is estimated to affect up to 30% of the world's population [26] . 79 With a reported trait heritability of 16-50% in humans [34; 60] The laboratory mouse has proven to be a useful discovery platform for the genetic study 88 of human chronic pain; findings from several mouse studies have been corroborated in humans 89 response scores per group at each 1 min time point over the 60 min formalin testing period. 238
Results were calculated and plotted over time in R software environment 3.0.
239
Trpa1 SNP analysis 240 A major benefit of the DO in mapping studies is the ability to precisely associate 241 observable phenotypic variation with specific underlying genetic variants. We identified putative 242 causal variants unique to CAST/EiJ in Trpa1 by examining the imputed DO genotype data used 243 to fit the additive SNP model at Nociq4. We selected SNPs with LOD scores greater than the 244 maximum LOD score (5.71) minus one and intersected them with the exons and untranslated 245 regions of Trpa1, obtained and processed computationally from NCBI dbSNP Build 150 [1; 69] . 246 We further subset these SNPs by selecting missense, splice site, or other regulatory variants 247 likely to produce a functional consequence (Sanger Mouse Genomes Project version 5; REL-248
[37]). 249 250

Electrophysiological evaluation of ankyrin domain variant 251
CAST/EiJ variant rs32035600 induces a Valine to Isoleucine codon shift (Val115Ile) in 252 the Trpa1 ankyrin repeat domain (ARD), a region of the folded protein known to influence the 253 electrophysiological properties of the channel [32; 44; 83] , and which is involved in the 254 aggregation of Trpa1 and Trpv1 receptors. We evaluated the electrophysiological consequence 255 of CAST/EiJ variant rs32035600 on Trpa1 channel conductance using whole-cell patch clamp 256 recording in HEK293T cells. 257
Cell line mutation 258
We obtained clone EX-Mm17807-M03 (Genecopoeia) for Trpa1 ORF driven by a CMV 259 promoter and a C-terminal GFP tag. Using site directed mutagenesis in E.coli, mouse SNP12 rs32035600 was mutated from the C57BL/6J (G) to the CAST/EiJ (A) variant. Both variants 261 were transfected into human embryonic kidney cells (HEK293T cells). HEK293T cells were 262 grown under standard conditions in DMEM with 10% FBS, Glutamax, and 263 penicillin/streptomycin, and were transfected with expression plasmids encoding GFP-tagged 264
Trpa1 carrying the two variants of interest. Cells were transfected using 500 ng of plasmid DNA 265 and 1.5 ul of Lipofectamine 3000 transfection reagent, according to the manufacturer's protocols. 266
Patch-clamp analysis 267
Forty-eight to 72 h after transfection, HEK293T cells grown on glass coverslips were transferred 268 to a submersion chamber where they were continuously perfused with extracellular recording 269 solution containing (in mM): 124 NaCl, 3.0 KCl, 1.5 CaCl 2 , 1.3 MgCl 2 , 1.0 NaH 2 PO 4 , 26 270 NaHCO 3 , and 20 glucose, saturated with 95% O 2 and 5% CO 2 at room temperature (21-23 °C). 271
Cells were viewed with a 40x objective (N.A. 0.8, water immersion) and transfected cells were 272 identified using GFP epifluorescence. Whole-cell patch clamp recordings were performed with a 273
Multiclamp 700B amplifier (Molecular Devices, Sunnyvale, CA). The pipette solution contained 274 (in mM): 130 CsCl, 4 ATP-Mg, 0.3 GTP-Na, 0.5 EGTA, and 10 HEPES (pH 7.2, 270-280 275 mOsm with sucrose). The series resistance, usually between 7-12 MΩ, was continuously 276 monitored but not compensated. Data were discarded when series resistance changed by more 277 than 25% during the experiment. Mustard oil (allyl isothiocyanate, Sigma-Aldrich, #377430) 278 was diluted in the extracellular solution to the concentration of 200 μM and applied through a 279 buffer pipette placed 40-50 μm away from the recorded cell. The buffer pipette had a tip 280 diameter of 2 μm and the pressure pulses were 10 s long at 20 psi. Experiments were conducted 281 using AxoGraph X (AxoGraph Scientific, Sydney, Australia). Data were filtered at 2 kHz and 282 digitized at 8 kHz. Data analysis was performed using AxoGraph X. 283 13 284
Evaluation of ankyrin binding interactions by Co-Immuno-Precipitation of Trpa1-Trpv1 285
The Val115Ile codon shift induced by CAST/EiJ variant rs32035600 may affect the 286 ability of Trpa1 to bind and co-localize with its functional partner Trpv1 (MGI:1341787; 287 transient receptor potential cation channel, subfamily V, member 1) [72] . To test this, we 288 performed Co-Immuno-Precipitation of the Trpa1-Trpv1 complex in mouse DRG from male and 289 female formalin and saline treated CAST/EiJ and C57BL/6J mice. Tissue extracts were prepared 290 using Lysis Buffer with Protease Inhibitors (LBPI; 300 μ L/sample). Samples were then 291 homogenized with a mortar/pestle, incubated at 4°C with gentle agitation for one hour followed 292 by centrifugation (Eppendorf 5417C) at 20000 x g for 20 minutes at 4°C to remove cell debris. 293
The supernatant/tissue extract was then transferred to a fresh microcentrifuge tube. DRG from pain-sensitive (C57BL/6J; n=7, 3 male) and pain-resistant (CAST/EiJ; n=8, 4 male) 316 mice. DRG were dissected and stored in RNAlater. RNA was extracted using TRIzol reagent, 317 quality assessed using Agilent Bioanalyzer Nano Chips. 200ng total RNA was converted to 318 cDNA using random-decamers. TaqMan assays were used to measure abundance of Trpa1 exon Table S3 ). Eight of the remaining 11 SNPs are synonymous coding exon variants. 386
The three remaining SNPs have consequences likely to influence the function or expression of 387
Trpa1: missense variant rs32035600 (Val115Ile; exon 3), 3' UTR variant rs215479411, and 388 splice region variant rs239908314 (intron 21) ( Table 1) The work described in this article represents the first application of DO mice to chronic 538 pain genetics research. Taken together, our results demonstrate that high-precision mapping of 539 pain-related genetic variants can be achieved with moderate numbers of DO animals, 540 representing a significant advance in our ability to leverage the mouse as a tool for the discovery 541 of pain-related genes and therapeutic targets. Precise genetic analysis enabled us to identify not 542 just the target gene, but three putative mechanisms of genetic effects on the phenotype. Trpa1a/b 543 isoform regulation is involved in sparing of the intact acute pain response, which is a necessary 544 sensory function, while specifically blocking the late phase response. Our results suggest that 545 facilitating the effects of the Trpa1a isoform may have beneficial and specific effects on chronic 546 but not acute pain. Applying our method of discovery to other pain-related traits may implicate 547 other pain-relevant genes and novel variant contributions to pain response, facilitating the 548 informed identification of therapeutics aided by the use of genetic precision to prioritize specific 549 sub-molecular targets. 550
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